Analyst Stan Berenshteyn from Wells Fargo reiterated a Buy rating on Veeva Systems (VEEV – Research Report) and keeping the price target at $285.00.
Stan Berenshteyn has given his Buy rating due to a combination of factors including Veeva Systems’ strong financial performance and promising future outlook. The company reported a notable earnings beat for the fourth quarter, with both revenue and EBIT exceeding expectations. This performance was complemented by a robust guidance for the fiscal year 2026, which was comfortably ahead of consensus estimates despite a challenging macroeconomic environment.
Furthermore, Veeva Systems is benefiting from strategic growth drivers such as increased commitments to its CRM Vault platform and advancements in its data cloud initiatives. The company’s focus on improving sales efficiency and shifting revenue mix towards higher-margin products adds to its appeal. Additionally, the valuation discount compared to peers presents an attractive risk/reward profile, supporting the potential for stock re-rating. These factors collectively underpin Berenshteyn’s confidence in the stock’s potential, justifying the Buy rating.
According to TipRanks, Berenshteyn is an analyst with an average return of -2.4% and a 56.63% success rate. Berenshteyn covers the Healthcare sector, focusing on stocks such as Omnicell, Veeva Systems, and Healthequity.
In another report released today, Barclays also maintained a Buy rating on the stock with a $275.00 price target.